
Results
12
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
12 companies
PharmaResearch
Market Cap: ₩4.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩425,500.00
7D
7.9%
1Y
-37.8%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,600.00
7D
6.2%
1Y
15.9%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,300.00
7D
8.3%
1Y
11.0%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩123,300.00
7D
-3.7%
1Y
-8.0%
Myung In Pharmaceutical
Market Cap: ₩689.1b
A pharmaceutical company, manufactures ETC and OTC drugs.
A317450
₩47,200.00
7D
4.5%
1Y
n/a
JW Holdings
Market Cap: ₩278.8b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,030.00
7D
5.8%
1Y
17.8%
Chong Kun Dang Holdings
Market Cap: ₩189.9b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩39,900.00
7D
0.5%
1Y
-15.9%
Ilyang PharmaceuticalLtd
Market Cap: ₩155.9b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,700.00
7D
2.7%
1Y
-32.9%
Ahn-Gook Pharmaceutical
Market Cap: ₩142.3b
Manufactures and sells pharmaceutical products.
A001540
₩12,520.00
7D
-0.3%
1Y
57.9%
Sinsin Pharmaceutical
Market Cap: ₩67.2b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,430.00
7D
2.5%
1Y
-22.0%
RP Bio
Market Cap: ₩54.7b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩6,310.00
7D
2.6%
1Y
-2.9%
Korean Drug
Market Cap: ₩38.1b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,495.00
7D
2.2%
1Y
-25.5%